Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Responsiveness as a Measure of Clinical Effectiveness During Neuromonitored Spine Surgery

NCT05110833 is registered in ClinicalTrials.gov with Allina Health System as lead sponsor.

NCT NCT05110833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05110833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Responsiveness as a Measure of Clinical Effectiveness During Neuromonitored Spine Surgery
Lead sponsor
Allina Health System
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 1, 2020
Completion date
April 30, 2026
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intervertebral disc degeneration, intervertebral disc displacement, spinal curvatures, spinal stenosis, spondylitis, spondylosis